x
Filter:
Filters applied
- Editor
- Research ArticleRemove Research Article filter
- aneuploidyRemove aneuploidy filter
Author
- Griffin, Darren K2
- Wells, Dagan2
- Bankowski, Brandon1
- Coates, Alison1
- Crain, Jack L1
- Gitlin, Susan A1
- Handyside, Alan H1
- Konstantinidis, Michalis1
- Kung, Allen1
- Michael Wilson, J1
- Munné, Santiago1
- Natesan, Senthilkumar A1
- Ottolini, Christian S1
- Patrick, Jennifer L1
- Sage, Karen1
- Summers, Michael C1
- Taylor, Tyl H1
- Thornhill, Alan R1
Editor's Choice
3 Results
- Article
Validation of next-generation sequencing for comprehensive chromosome screening of embryos
Reproductive BioMedicine OnlineVol. 31Issue 6p760–769Published online: September 9, 2015- Allen Kung
- Santiago Munné
- Brandon Bankowski
- Alison Coates
- Dagan Wells
Cited in Scopus: 89Massively parallel genome sequencing, also known as next-generation sequencing (NGS), is the latest approach for preimplantation genetic diagnosis. The purpose of this study was to determine whether NGS can accurately detect aneuploidy in human embryos. Low coverage genome sequencing was applied to trophectoderm biopsies of embryos at the blastocyst stage of development. Sensitivity and specificity of NGS was determined by comparison of results with a previously validated platform, array-comparative genomic hybridization (aCGH). - Article
Live birth after PGD with confirmation by a comprehensive approach (karyomapping) for simultaneous detection of monogenic and chromosomal disorders
Reproductive BioMedicine OnlineVol. 29Issue 5p600–605Published online: July 25, 2014- Senthilkumar A. Natesan
- Alan H. Handyside
- Alan R. Thornhill
- Christian S. Ottolini
- Karen Sage
- Michael C. Summers
- and others
Cited in Scopus: 50Preimplantation genetic diagnosis (PGD) for monogenic disorders has the drawback of time and cost associated with tailoring a specific test for each couple, disorder, or both. The inability of any single assay to detect the monogenic disorder in question and simultaneously the chromosomal complement of the embryo also limits its application as separate tests may need to be carried out on the amplified material. The first clinical use of a novel approach (‘karyomapping’) was designed to circumvent this problem. - Article
Outcomes of blastocysts biopsied and vitrified once versus those cryopreserved twice for euploid blastocyst transfer
Reproductive BioMedicine OnlineVol. 29Issue 1p59–64Published online: March 17, 2014- Tyl H. Taylor
- Jennifer L. Patrick
- Susan A. Gitlin
- J. Michael Wilson
- Jack L. Crain
- Darren K. Griffin
Cited in Scopus: 34Trophectoderm biopsy with comprehensive chromosome screening (CCS) has been shown to increase implantation and pregnancy rates. Some patients desire CCS on previously cryopreserved blastocysts, resulting in blastocysts that are thawed/warmed, biopsied, vitrified and then warmed again. The effect of two cryopreservation procedures and two thawing/warming procedures on outcomes has not been effectively studied. Cycles were divided into two groups: group 1 patients underwent a cryopreserved embryo transfer with euploid blastocysts that were vitrified and warmed once; group 2 patients had a cryopreserved embryo transfer of a euploid blastocyst that was cryopreserved, thawed/warmed, biopsied, vitrified and warmed.